PubMed:11201732 / 559-700
Annnotations
2015-BEL-Sample
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-141 | a(CHEBI:rosiglitazone) decreases sec(p(MGI:Retn)) | denotes | Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity |
2015-BEL-Sample-2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
BEL:20000264 | 0-141 | path(MESHD:Obesity) increases sec(p(MGI:Retn)) | denotes | Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity |
BEL:20000266 | 0-141 | a(CHEBI:rosiglitazone) decreases sec(p(MGI:Retn)) | denotes | Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity |